.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Chinese Patent Office
Dow
Healthtrust
Julphar
Cipla
Accenture
Chubb
Queensland Health

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202813

« Back to Dashboard
NDA 202813 describes QNASL, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the QNASL profile page.

The generic ingredient in QNASL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for NDA: 202813

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202813

Suppliers and Packaging for NDA: 202813

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL 202813 NDA Teva Respiratory, LLC 59310-206 59310-206-06 1 INHALER in 1 CARTON (59310-206-06) > 60 AEROSOL, METERED in 1 INHALER
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL 202813 NDA Teva Respiratory, LLC 59310-206 59310-206-08 1 INHALER in 1 CARTON (59310-206-08) > 60 AEROSOL, METERED in 1 INHALER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;NASALStrength0.08MG/ACTUATION
Approval Date:Mar 23, 2012TE:RLD:Yes
Patent:7,780,038Patent Expiration:Jan 24, 2027Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;NASALStrength0.04MG/ACTUATION
Approval Date:Dec 17, 2014TE:RLD:Yes
Patent:7,780,038Patent Expiration:Jan 24, 2027Product Flag?YSubstance Flag?Delist Request?
Regulatory Exclusivity Expiration:Dec 17, 2017
Regulatory Exclusivity Use:NEW STRENGTH

Expired Orange Book Patents for NDA: 202813

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,683,677► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 20145,776,432► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,605,674► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,776,432► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Baxter
Express Scripts
Cipla
Julphar
Merck
Chubb
Teva
Accenture
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot